Skip to main content

The function and biomarker potential of mitochondrial microRNAs in hypertension

Searching for OpenAIRE data...


Noncoding RNAs in age-related cardiovascular diseases

Author(s): Amela Jusic, Pınar Buket Thomas, Stephanie Bezzina Wettinger, Soner Dogan, Rosienne Farrugia, Carlo Gaetano, Bilge Güvenç Tuna, Florence Pinet, Emma L. Robinson, SimonTual-Chalot, Konstantinos Stellos, Yvan Devaux, On behalf of EU-CardioRNA COST Action CA17129
Published in: Ageing Research Reviews, Volume 77, 2022, Page(s) 101610, ISSN 1568-1637
Publisher: Elsevier BV
DOI: 10.1016/j.arr.2022.101610

(Epi)transcriptomics in cardiovascular and neurological complications of COVID-19

Author(s): Amela Jusic, Konstantinos Stellos, Lino Ferreira, Andrew H.Baker, Yvan Devaux
Published in: Journal of Molecular and Cellular Cardiology Plus, Volume 1, September 2022, 100013, 2022, ISSN 2772-9761
Publisher: Science Direct
DOI: 10.1016/j.jmccpl.2022.100013

Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129

Author(s): Lina Badimon, Emma L Robinson, Amela Jusic, Irina Carpusca, Leon J deWindt, Costanza Emanueli, Péter Ferdinandy, Wei Gu, Mariann Gyöngyösi, Matthias Hackl, Kanita Karaduzovic-Hadziabdic, Mitja Lustrek, Fabio Martelli, Eric Nham, Ines Potočnjak, Venkata Satagopam, Reinhard Schneider, Thomas Thum, and Yvan Devaux, on behalf of EU-CardioRNA COST Action CA17129
Published in: Cardiovascular Research, Volume 117, Issue 8, 2021, Page(s) 1823–1840, ISSN 1755-3245
Publisher: Oxford University Press
DOI: 10.1093/cvr/cvab094

‘’Epigenetics in Cardiovascular Disease’’: section III, Biomarker value: Chapter 14. Long non-coding RNAs and circular RNAs as heart failure biomarkers

Author(s): Amela Jusic, Yvan Devaux
Published in: The Elsevier S&T books: ‘’Epigenetics in Cardiovascular Disease’’, 2021, Page(s) 303-326
Publisher: Academic Press
DOI: 10.1016/b978-0-12-822258-4.00009-2